Abamune-L is triple-combination antiretroviral therapy is prescribed for:
- Management of HIV-1 infection
- Reduction of viral load in bloodstream
- Prevention of AIDS progression
- Lowering HIV transmission risk
Mechanism of Action
- All three components are nucleoside reverse transcriptase inhibitors (NRTIs) that:
- Block HIV replication process
- Reduce viral RNA levels
- Help restore immune function
Dosage & Administration
- Take one tablet twice daily
- May be taken with/without food
- Maintain strict 12-hour dosing schedule
- Never alter dosage without medical supervision
Critical Patient Instructions
- Lifelong adherence required for effectiveness
- Does not eliminate HIV transmission risk
- Must be combined with safer sex practices
- Never interrupt treatment without consulting physician
Important Safety Considerations
- Hypersensitivity risk: Requires immediate discontinuation if reaction occurs
- HLA-B*5701 testing mandatory before initiation
- Treatment interruptions may cause:
- Viral resistance
- Severe allergic reactions upon restarting
Storage: Keep at room temperature (15-30°C) in original packaging
Note: Regular viral load monitoring essential. Report any new symptoms immediately to healthcare provider.
